The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2021 Euromoney, a part of the Euromoney Institutional Investor PLC.
Banking

Supranationals: IFFIm: a supra new borrower?

Highly unusual and interesting vehicle, but its precise status remains ambiguous.





Doris Herrera-Pol, World Bank



“The impression we got from our visits was that investors would welcome another name – given that there are not that many supranationals and the supply of bonds from many of us has declined”
Doris Herrera-Pol, World Bank

It has taken more than a year for the first deal from the International Finance Facility for Immunization (IFFIm) to appear since it was unveiled a year ago. Normal questions concerning pricing and placement will of course need answering. And the leads, Goldman Sachs and Deutsche Bank, indicate that they will raise between $500 million and $1billion for the inaugural deal. It’s a modest amount but, given that IFFIm only requires $4 billion over the next four years, it doesn’t really need volume right now. What is really interesting about IFFIm is that it is the first serious collective attempt for many years to make an impact on Third World poverty via the capital markets.

It also makes an important argument for project targeted aid. The argument is that taxpayers will be more comfortable contributing aid in this form than through traditional government operations that result in aid assistance being expressed as a percentage of GDP.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.

SUBSCRIBE ONLINE TODAY

Unlimited access to Euromoney.com and Asiamoney.com

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually

FREE 7 DAY TRIAL

Unlimited access to Euromoney.com and Asiamoney.com, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors

LOGIN NOW

Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree